These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10725055)

  • 1. Disbursement of indemnity for injuries related to reproductive drugs and devices: a Swedish perspective.
    Westerhall L
    Rev Law Soc Change; 1997; 23(3):443-56. PubMed ID: 10725055
    [No Abstract]   [Full Text] [Related]  

  • 2. The Danish patient insurance scheme. A comparison with the Swedish system.
    Krenchel JV; Broberg MP
    J Leg Med; 1995 Sep; 16(3):407-15. PubMed ID: 7595047
    [No Abstract]   [Full Text] [Related]  

  • 3. Wyeth Pharmaceutical's perspective on vaccine production.
    Stiles GL
    Md Med; 2005; 6(1):22-3. PubMed ID: 15869103
    [No Abstract]   [Full Text] [Related]  

  • 4. Health workforce redesign in Australia: implications for health care professional liability and the provision of professional indemnity insurance.
    Keaney M
    J Law Med; 2008 Feb; 15(4):494-500. PubMed ID: 18365516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes for concern and causes of action: a comment on "Pushing drugs".
    Brownsword R
    Washburn Law J; 2003; 42(3):601-14. PubMed ID: 15115002
    [No Abstract]   [Full Text] [Related]  

  • 7. Qui tam: False Claims Act.
    Salcido R
    Adv Skin Wound Care; 2010 Nov; 23(11):487. PubMed ID: 20975328
    [No Abstract]   [Full Text] [Related]  

  • 8. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 9. Authorized generics.
    Glass G
    Nat Rev Drug Discov; 2005 Dec; 4(12):953-4. PubMed ID: 16370080
    [No Abstract]   [Full Text] [Related]  

  • 10. Litigation plays protective role--and is part of the problem.
    Kennett JD
    Mo Med; 2007; 104(1):12-3. PubMed ID: 17410818
    [No Abstract]   [Full Text] [Related]  

  • 11. The Canadian perspective: trends in drug and medical device class actions in Canada.
    Vernon W
    Food Drug Law J; 2006; 61(3):569-76. PubMed ID: 16989040
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunity for immunizations: tort liability, biodefense, and Bioshield II.
    Mayer L
    Stanford Law Rev; 2007 Apr; 59(6):1753-90. PubMed ID: 17593591
    [No Abstract]   [Full Text] [Related]  

  • 13. Research on contraception still in the doldrums.
    Holden C
    Science; 2002 Jun; 296(5576):2172-3. PubMed ID: 12077399
    [No Abstract]   [Full Text] [Related]  

  • 14. Wyeth responds to criticism.
    Stiles GM
    Md Med; 2005; 6(4):5, 7-8; author reply 8. PubMed ID: 16454430
    [No Abstract]   [Full Text] [Related]  

  • 15. Bill 102: deal or no deal for big pharma.
    Rasky H
    Health Law Can; 2007 May; 27(4):73-84. PubMed ID: 17580795
    [No Abstract]   [Full Text] [Related]  

  • 16. Mea culpa: are multi-billion dollar fines forcing drug companies to clean up their act?
    Jack A
    BMJ; 2012 Jul; 345():e4865. PubMed ID: 22809803
    [No Abstract]   [Full Text] [Related]  

  • 17. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug pricing. AHF to file suit against Glaxo for African AIDS-related deaths.
    AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974398
    [No Abstract]   [Full Text] [Related]  

  • 19. The politics of the flu vaccine shortage.
    Stulc JP
    J Ky Med Assoc; 2004 Dec; 102(12):563-4. PubMed ID: 15636192
    [No Abstract]   [Full Text] [Related]  

  • 20. [The advertising rights of medical representatives. 2: Presentation of the legal advertising framework according to the drug advertising law].
    Hüttl P; Heberer J; von Knoch M; Siegert M
    Chirurg; 2007 Dec; Suppl():421-5. PubMed ID: 18546571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.